143 related articles for article (PubMed ID: 22391053)
21. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
22. Adverse effects after radiotherapy for early stage (I,IIa,IIb) seminoma.
Majewski W; Majewski S; Maciejewski A; Kolosza Z; Tarnawski R
Radiother Oncol; 2005 Sep; 76(3):257-63. PubMed ID: 15921773
[TBL] [Abstract][Full Text] [Related]
23. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
24. Mortality after cure of testicular seminoma.
Zagars GK; Ballo MT; Lee AK; Strom SS
J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients.
Andolino DL; Hoene T; Xiao L; Buchsbaum J; Chang AL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e667-71. PubMed ID: 21459527
[TBL] [Abstract][Full Text] [Related]
26. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
28. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
[TBL] [Abstract][Full Text] [Related]
29. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis.
Niazi TM; Souhami L; Sultanem K; Duclos M; Shenouda G; Freeman C
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):741-4. PubMed ID: 15708252
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminoma.
Zilli T; Boudreau C; Doucet R; Alizadeh M; Lambert C; van Nguyen T; Taussky D
Acta Oncol; 2011 May; 50(4):555-62. PubMed ID: 21413852
[TBL] [Abstract][Full Text] [Related]
32. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
[TBL] [Abstract][Full Text] [Related]
33. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy for stage I seminoma of the testis.
Yoney A; Yildirim C; Isikli L; Akboru H; Unsal M
Indian J Cancer; 2010; 47(2):179-83. PubMed ID: 20448383
[TBL] [Abstract][Full Text] [Related]
35. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
36. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.
Hallemeier CL; Davis BJ; Pisansky TM; Choo R
Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645
[TBL] [Abstract][Full Text] [Related]
37. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
[TBL] [Abstract][Full Text] [Related]
38. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
39. Comparative treatment planning using secondary cancer mortality calculations.
Schneider U; Lomax A; Lombriser N
Phys Med; 2001; 17 Suppl 1():97-9. PubMed ID: 11770547
[TBL] [Abstract][Full Text] [Related]
40. The effect of radiotherapy treatment changes on sites of relapse in stage I testicular seminoma.
Taylor MB; Carrington BM; Livsey JE; Logue JP
Clin Radiol; 2001 Feb; 56(2):116-9. PubMed ID: 11222068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
